CLINICAL TRIALS PROFILE FOR UNOPROSTONE ISOPROPYL
✉ Email this page to a colleague
All Clinical Trials for UNOPROSTONE ISOPROPYL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01379560 ↗ | A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular Degeneration | Completed | Sucampo Pharmaceuticals, Inc. | Phase 2 | 2011-05-01 | The purpose of this study is to determine the pharmacodynamics of ocular blood flow measurements with multiple drop unoprostone isopropyl administration versus placebo in subjects with dry age-related macular degeneration (AMD). |
NCT01379560 ↗ | A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular Degeneration | Completed | Sucampo Pharma Americas, LLC | Phase 2 | 2011-05-01 | The purpose of this study is to determine the pharmacodynamics of ocular blood flow measurements with multiple drop unoprostone isopropyl administration versus placebo in subjects with dry age-related macular degeneration (AMD). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for UNOPROSTONE ISOPROPYL
Condition Name
Clinical Trial Locations for UNOPROSTONE ISOPROPYL
Clinical Trial Progress for UNOPROSTONE ISOPROPYL
Clinical Trial Phase
Clinical Trial Sponsors for UNOPROSTONE ISOPROPYL
Sponsor Name